Ads
related to: moderna stock news update today in the philippines per region freelp.stockstotrade.com has been visited by 10K+ users in the past month
schwab.com has been visited by 100K+ users in the past month
Search results
Results From The WOW.Com Content Network
A bad seven-month stretch just got worse for Moderna (NASDAQ: MRNA). This update wasn't well-received by investors, and Moderna's share price sank nearly 17%. Moderna's stock chart certainly looks ...
Shares of Moderna (NASDAQ: MRNA) zoomed as much as 33.3% higher this week, according to data from S&P Global Market Intelligence. The maker of vaccines, including the mRNA vaccine for COVID-19, is ...
Although the company has made progress in reducing costs and improving financial efficiency, the year-to-date per-share earnings loss of $6.37 was only an improvement compared to the $12.89 loss ...
Without a growing base of revenue, it's hard to craft a compelling investment thesis for Moderna or any other stock. Moderna's trailing-12-month revenue is just over $5 billion, down by 77% from ...
There was good news to share, but the market focused on a declining sales forecast and hammered the stock lower. Last November, Moderna said it expected 2024 revenue to land in a range between $3 ...
But Moderna's news hasn't been as bright recently. Last month, the company revised coronavirus vaccine revenue downward due to lower sales. And in its update this week, the biotech made ...